Posted by AGORACOM-JC
at 4:38 PM on Friday, December 17th, 2021
Valeo Pharma is already a successful, revenue-generating, small cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.
This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small cap pharma companies.
Q3 Highlights:
Record revenues of $5.7 million for Q3 2021, up 280% over Q3 2020 and 114% over prior quarter.
Record gross margin of $2.2 million , up 1602% over Q3 2020 and 204% over prior quarter.
Record 9 months revenues at $10.2 million , up 94%
Public reimbursement now includes Alberta , Quebec and Nova Scotia , representing approximately 37% of the Canadian population.
More than 90% private insurance coverage across Canada
Frederic Fasano, Valeo’s President and Chief Operating Officer commented,
“We are pleased to be reporting today the addition of Quebec and Nova Scotia to join Alberta on the list of provincial public coverage secured for both asthma medications. Public Reimbursement access makes a meaningful impact for asthma patients left with no coverage so far, and also simplify health care providers procedures to provide access of both medications to their patients. Enerzair and Atectura are innovative asthma therapies that are helping make asthma control a more attainable goal for Canadians asthma patients”.
Posted by AGORACOM
at 4:43 PM on Thursday, December 16th, 2021
Cross River Ventures is focused on the development of top tier exploration properties in the premier mining district of Red Lake Ontario exploring for gold, and for several good reasons.
The Red Lake Mining jurisdiction hosts one of the largest mineral rich greenstone belt on the planet that has produced 200 million ounces of gold in over 100 years of mining. This includes a total gold endowment exceeding 300million ounces with over 124 mines and 21 plus deposits with more than 3 million ounces each.
Cross River hosts 7 Projects (over 28,000-hectares) within the prolific greenstone belts of NW Ontario, Canada which host the most productive gold deposits in the world.
This is where Cross River is targeting gold for discovery potential.
Armed with a world class technical team led by Dr. Rob Carpenter, who was the CEO of Kaminak, ( acquired by Goldcorp for CDN $520 million), know how to plan and execute a exploration program designed specifically to make a discovery.
Cross Rivers Flagship McVicar Property is just one of the properties they are targeting for discovery. Situated close to the 3.8m Oz Springpole deposit controlled by First Mining Gold Corp. ( FF.TO ) it hosts 2 mineralized trends that are parallel to one another and include new surface discoveries of gold, as well as previous sampling of high grade with numerous results greater than 500g/t gold.
McVicar is ready to be fully explored and drill permits for the property have been issued for multiple target areas delineated via modern geophysics.
The recent driver of attention to the Red Lake area is the takeover of Great Bear Resources by Kinross Gold Corp. under which Kinross has agreed to acquire all of the outstanding common shares of the Red Lake explorer for C$29.00 per share, approximately $1.8-billion and being done without a resource calculation. This is primarily due to the excellent nature of their drill results.
The peer takeover speaks to the attractiveness of discovery potential and quality of the mining jurisdiction. Cross River is in the right neighborhood to make a discovery, at the right time in the market, and when attention in the area has never been greater.
Sit back and enjoy this great interview with Cross River Venture CEO Alex Klenman as he walks us through their objective to make a discovery equal to their peers in the Red Lake Mining District.
Posted by AGORACOM-JC
at 9:09 AM on Thursday, December 16th, 2021
An emerging esports and iGaming company that is creating an Esports adventure like no other …. Create the world’s foremost esports and iGaming ecosystem.
The global online gambling market could potentially hit $1 TRILLION by the end of this decade. The obvious reasons include the following:
Exponential growth in the number of people online. Yet only 59% of the world means more to come.
Fast growth in the number of countries and jurisdictions legalizing gambling to collect tax revenue.
Esports was already the fastest growing sub-sector of digital entertainment, and Covid 19 has only accelerated this trend.
Biggest brands/tournament prizes / online audiences in the world … 500M +
The International Olympic Committee has recognized esports as a sport, and it will be a medal event at the 2022 Asian Games
Despite the vast amount of viewers, esports is still dramatically under-monetized relative to traditional sports. ITM believes wagering will play a major role in helping monetize this ever-evolving platform.
Intema has had an active first half of December evident by the following:
Goal of expanding Intema’s esports and iGaming operations in the U.S.
letter of intent with Wild Rose Entertainment to operate a LOOT.BET sports wagering skin in the state of Iowa
Betting handle in Iowa estimated at more than US$1 billion in 2021, having reached $287 million in November 2021 (Source: gambling.com, December 10, 2021)
Laurent Benezra, President and CEO of Intema,
“We are thrilled to welcome Bill to the Intema team and are impressed with what he has managed to accomplish in a very short period of time. The LOI with Wild Rose is just the beginning of what the LOOT.BET platform could bring to Intema once its acquisition is finalized.”
“The grant of the Isle of Man gambling license is major news for Intema and will have a significant positive impact on our future activities. In particular, it allows us to comply with one of the TSX Venture Exchange’s main conditions for closing the acquisition of Livestream Gaming Inc. (“ Livestream ”), with its LOOT.BET online gaming platform. It will also enable us to conduct our iGaming activities through one of the world’s most prestigious gaming jurisdictions and, once we acquire our LOOT.BET platform, to white-label it to regulated gaming markets on a global scale. Finally, it gives LOOT.BET the same level of credibility as other online gambling platforms, throughout the gaming community and among our peers.”
Sit back, relax and watch this powerful interview.
Salt Lake City Clinic welcomes incoming addictions specialist, Dr. Amy de la Garza
We are pleased to announce the opening of a new clinic located in downtown Salt Lake City (SLC). In addition to Novamind’s suite of mental health treatments, the SLC Clinic specializes in integrative behavioural health and services for adults with substance use disorders (SUD) led by incoming Medical Director, Dr. Amy de la Garza.
The SLC Clinic’s outpatient SUD services provide an alternative to residential treatment programs and work to address the highly complex public health crisis that is worsening alongside challenges related to access. In 2020 alone, 93,000 Americans died of a drug overdose-an increase of 30 per cent from the previous year, according to the Centers for Disease Control and Prevention.
Dr. Reid Robison, Novamind’s Chief Medical Officer, commented: “Social isolation and despair related to the COVID-19 pandemic have further fueled a significant increase in substance use disorders and related deaths. Dr. de la Garza’s expertise in addiction medicine and behavioural health is a vital addition to our team as we continue to expand Novamind’s clinic footprint to address unmet need and broaden our innovative, evidence-based treatments.”
Dr. de la Garza is a board-certified family practice physician with 10 years of experience providing specialized care for patients with behavioral health and SUD diagnoses. She earned her Doctorate in Medicine from the University of Colorado before completing a Family Medicine Residency at the Utah Healthcare Institute. She also completed an Addiction Medicine Fellowship at the University of Utah and is an Institute for Functional Medicine Certified Practitioner. In 2017, Dr. de la Garza opened the first community-based, co-located primary care and behavioral health practice in Salt Lake City, Utah.
“I am thrilled to join Novamind and look forward to establishing an innovative outpatient substance use disorder program that brings together addiction and integrative medicine and treats the whole person,” said Dr. de la Garza, who is also trained in integrative modalities and lifestyle medicine, including nutrition, movement, sleep, stress management and social connection.
Novamind will collect clinical data on the efficacy of the integrative treatment approach for SUD and host upcoming studies for conditions like opioid use disorder. Additionally, the SLC Clinic will pilot an innovative and cost-effective group medical visit model that has been shown to reduce anxiety and depression, as well as improve outcomes in chronic conditions like cardiovascular disease and diabetes.
The SLC Clinic is located at 807 E South Temple, Suite 101, Salt Lake City, Utah.
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison explore anxiety. They discuss the following topics and much more: • What is an anxiety disorder? • Anxiety management skills • The role of medicines in treating anxiety
Utah Business covers Dr. Reid Robison and the success of ketamine-assisted psychotherapy in our clinics. “While it’s still early and much more testing is to be done, Robison describes what’s happening in mental health care as a ‘psychedelic renaissance’.”
Dr. Reid Robison, Matt Johnson and Robin Carhart-Harris discuss The Science of Psychedelics: Therapeutic mechanisms and clinical outcomes for a range of mental illnesses and other conditions.
Chief Medical Officer Dr. Reid Robison’s keynote presentation at the Mind Medicine Australia International Summit on Psychedelic Therapies for Mental Illness.
“While the U.S. has been battling Covid-19 it’s gotten lost in the shuffle that the nation had record numbers of drug overdose-related deaths in 2020; approximately 93,000. In addition, from May 2020 through April 2021, the figure rises to 100,000.” We need better treatment options for people with substance use disorders (SUD). It’s the driving force behind why incoming Novamind Medical Director Dr. Amy de la Garza will lead SUD programming at our new Salt Lake City clinic.
We are currently in a mental health crisis. Depression, anxiety and symptoms of PTSD have run rampant over the last two years, accelerated by the COVID-19 pandemic and its far-reaching effects. The need for new and effective mental health treatments has never been clearer. We have seen the efficacy of ketamine-assisted psychotherapy firsthand. And we are eager to continue psychedelic research. If you’d like to stay up to date on upcoming studies hosted by Novamind, visit us here and get in touch. “So what else does the future hold for psychedelics? For one thing, taking psychedelics could one day be the same as taking an everyday pill prescribed by your doctor.”
Posted by AGORACOM-JC
at 5:45 PM on Thursday, December 9th, 2021
HypeX.gg recently acquired by Intema Solutions (ITM: TSXV) (ITMZF: OTC) has two divisions;
Retail
HypeX.gg is an Esports tournament and social platform.
Commercial
HypeX is a next-gen advertising platform specializing in endemic & non-endemic advertising opportunities.
HypeX has refined Esports demand into three major categories of individuals
Athletes,
Audience members and
Content creators.
By designing functionality & incentive to appeal to these three categories, HypeX creates seamless advertising opportunities for retail brands, organizations and companies.
HypeX is able to elicit specific consumer behaviours on behalf of the brand, offering a significantly greater ROI on their advertising budget.
HypeX has proven to be the home of Free-to-Enter tournaments with $100,000 + in prizes already paid out. In addition, the company boasts 50,000+ Users and has 20+ brand partnerships.
Posted by AGORACOM
at 11:53 AM on Monday, December 6th, 2021
Shareholders & friends,
Off the back of announcing our deals with Times Internet and Polygon ($MATIC), I wanted to end the week with a personal note. This week was a watershed moment for GameOn. A moment when a small, relatively unknown CA$20 million market cap company became backed by India’s largest media conglomerate and a leading blockchain with a US$22 billion market cap. This is strong validation of the mission, products and team that fuel our business each day.
While many don’t know who we are yet, that’s now shifting. Just yesterday, we were written up by VentureBeat, a tech news leader that receives 12 million monthly views and is regularly read by Mark Zuckerberg. I was also recently featured in Forbes. Both customers and investors are being awoken by the noise we’re making, and they’re starting to take note.
While the market has been choppy, we’ve quietly had our heads down building and closing deals. 2022 is set up to be the year of scaling customers and revenue. If you’ve followed us since listing, you’ll know we execute on what we say we will. We expect the next 12-24 months to be no different. The first inning is over. Batter up for the second, now with the likes of Times Internet and Polygon on-deck.
Look out for a more detailed corporate update next week. In the meantime, thank you for the ongoing support. Have a great weekend!
Cheers, Matt
Polygon Studios Invests in GameOn, Strategically Partners to Bring NFT Games to the MassesGameOn Secures Up to US$6 Million in Strategic Investment from India’s Brand Capital International
Multistate expansion underway, signed LOI to acquire Arizona-based mental health practice
Total revenue of $1,857,750, +113% when compared to same period last year
Total working capital of $6,834,011 to fund operations
“Q1 was a strong start to fiscal year 2022, driven by the addition of another clinic to our network and increased patient demand for our comprehensive range of innovative mental health treatments,” said Yaron Conforti, Novamind’s CEO and Director. “We continue to make progress on our national clinic expansion, most recently with a letter of intent to acquire two locations in Arizona. Our clinical research business has been actively building an exciting pipeline of contracts with leading drug developers.”
“Novamind operates best-in-class psychiatry clinics and clinical research sites, with a proven ability to replicate our clinic model in the U.S. Our agreement with Bienstar is an exciting opportunity to export our clinical expertise and capabilities into international markets,” said Yaron Conforti, Novamind CEO and Director. “Partnering with local operators allows us to disseminate Novamind’s best practices and SOPs globally, with minimal investment and managed risk, ultimately expanding access to psychedelic medicine and innovative mental healthcare on a global scale.”
Novamind’s CEO and Director, Yaron Conforti, will join the Psychedelics Assisted Psychotherapy panel discussion from 1:30 PM to 2:15 PM EST. Mr. Conforti will also deliver a corporate presentation to update investors on recent milestones and progress towards the global expansion of Novamind’s psychedelic clinics and research sites.
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison explore the concept of the “middle way” and the need for balance in an increasingly polarized world.
In a piece for The Guardian, psychedelic pioneer Rick Doblin explains how psychedelics can change humanity for the better. “We envision a day when psychedelics will be more than a last-ditch treatment: they will be a catalyst for mass mental health.”
The work to destigmatize psychedelics has been long and arduous. Just ask Rick Doblin. He’s devoted his life to it. But as more and more research comes out, more and more people are changing their opinion on the once villainized substances. “Public attitudes around psychedelics are shifting: A recent Nanos Research survey, commissioned by the Canadian Psychedelic Association, found that 82 per cent of Canadians are in favour of psilocybin-assisted therapy in end-of-life illness, while 78 per cent of those polled support legalizing it to improve the quality of life for palliative and end-of-life patients.”
Posted by AGORACOM-JC
at 6:23 PM on Wednesday, December 1st, 2021
As the name implies, ImagineAR (IP:CSE / IPNFF:OTCQB) is an Augmented Reality Company … but they’re not just any AR company. Imagine enables businesses to create their own mobile phone AR campaigns with no programming or technology experience.
Why is that important? Ask Apple CEO Tim Cook who stated
“AR Will play an important role in how we use technology in the future – and promises to be as influential in our society as the smartphone”
For those of you that are just discovering Augmented Reality, “AR” is essentially a technology that lays digital images and graphics over the real world, typically by looking through your cell phone or special glasses. If you think it sounds like a gimmick, it isn’t. AR will create an entirely new revenue stream for businesses, organizations and sports teams that will boggle the mind in the next 3 years.
ImagineAR provides small-cap investors with an opportunity to participate in the growth of this mega-market in the making …. and IP delivered record revenues in the first 9 months of the year with a 385% increase over last year to prove it, thanks to deals and announcements as follows:
Tier-1 Clients
Shoppers Drug Mart
NFL Alumni,
2 biggest soccer teams in Spain – Valencia / Real Sociedad
Club Atletico Mineiro (Brazil)
Grubhub Sound Bites: Megan Thee Stallion, Noah Cyrus
Hype Sports Global Accelerator Program where it was selected by 18 various sports teams, leagues, and broadcasters including
SPORTS – Vegas Knights, Philadelphia Phillies,
ESPORTS – SK Gaming; FC Koln
MEDIA – Sinclair Broadcasting, Rogers Communications,
What did Alen Paul Silverrstieen, CEO and President of Imagine AR have to say;
“To be selected as a 2021 STA Startup Category Stage Winner for Fan Engagement is truly an honor and further positions our company as one of the up-and-coming global sports tech leaders,” said “This STA selection can open up new sales and partnership opportunities for ImagineAR as well throughout the world. We are excited to compete against other global winners for the overall 2021 Startup of the Year Award in the near future.”
Using the FameDays TM mobile app for both IOS and Android, fans can enjoy birthday, holiday, superfan hologram video messages right in their home and record their own videos and pics with the virtual star as if they are standing right next to them in real life and share in social media. Premiere hologram stars are expected to include NFL & MLB Superstars, Reality TV Stars, Pro Wrestlers and new celebrity holograms to be added regularly.
Is this worth getting excited about?
Did you know….
Sit back, relax and watch this powerful interview with Alen Paul Silverrstieen, CEO and President of Imagine AR.
Steven McAuley, Chairman and CEO of Empower commented:
“This quarter marked the start of a new chapter for the Company and the Empower team. We launched The Medi-Collective brand and clinics, expanded Kai Labs’ facilities and completed the acquisition of MediSure. Each of these milestones is an intrinsic aspect of our strategic growth vision.“
Key Q3-2021 Highlights:
Revenue from continuing operations of $405,707 compared to $85,960 in Q3 2020, representing 372% year-over-year growth.
Revenue from continuing operations of $3,226,335 for nine months YTD 2021 compared to $222,690 for nine months YTD 2020, representing 1,349% year over year growth.
What does CEO Steven McAuley think of these results?
“With positive year-over-year growth coming out of this quarter, we will maximize our fully operational divisions’ capabilities and reach across Canada and the U.S. I’m encouraged by our partnerships and acquisitions progress into Q4 2021 and look forward to the coming months.”
Sit back, relax and watch this powerful interview.
We are pleased to launch our new logo and announce that the Company will unite its subsidiaries and brands under a single Novamind brand.
Novamind is investing in a revitalized and unified brand following a year of significant growth including expansion into new states, launching new clinics and research sites and bringing to market several innovative mental health care offerings.
Novamind’s new logo is now live on its corporate website and social media platforms. The logo integrates and flows across all digital and physical properties, and represents Novamind’s core beliefs in hope, healing and transformation. The open doorway at the centre of the logo, working in conjunction with the radiating lines, is an invitation towards an improved way of life—one where taking care of mental health is a priority.
The logo reveal kicks off the multi-phase rebrand of the Company’s network of clinics and research sites, expected to be complete in 2022. The Company is also improving its website to scale alongside its growth strategy and better serve diverse audiences with enhanced content and tools. Taking inspiration from the revitalized logo, the website will provide an accessible digital entry point to Novamind’s world-class care and clinical research offerings.
Yaron Conforti, CEO and Director, commented: “The new logo, rebrand and website reflects our rapid evolution over the last year. It’s an exciting opportunity to unify our current and future assets under one unique identity that will become a trusted and recognized name for innovative mental healthcare in communities across the U.S.”
In this episode of the Psychedelic Therapy Frontiers podcast, Hannah Cross is back and joinsDr. Steve Thayer and Dr. Reid Robison to explore psycho-spiritual emergencies. Hannah is a licensed clinical social worker, therapist, reiki master and yoga teacher.
Could MDMA-assisted therapy be a treatment for alcohol use disorder? A new study says psychotherapy under the influence of the drug MDMA could help patients process the traumatic experiences that are often the root cause of this condition. Psychedelics have long been considered in the treatment of alcohol use disorder, with scientists in the ‘60s hypothesizing that it might. Click the link above to learn more about MDMA and alcohol use disorder. Learn more about LSD and alcohol use disorder here.
Virtual reality could be the next great digital frontier. And thinking has already begun for how it can advance the mental health revolution we are currently in. “The use of VR in medical settings to provide emotional care is not a new concept. Over the past several years VR has been employed with greater frequency and effectiveness in ways large and small. Recently, the staff at a hospital in Long Beach, California, used virtual reality tech in a simple yet valuable context, distracting young patients during medical procedures like removing a cast.”
Your genetics may hold some clues as to how psychedelics might affect you. But the test isn’t perfect and results should be taken with a grain of salt: “The test covers five different DNA markers for psychedelic sensitivity, metabolism, and mental health risk. However, some of the conclusions drawn by HaluGen are oversimplified or based on outdated science, experts told VICE.”
Researchers from the Yale Department of Psychiatry were awarded a US$2 million grant for a first-of-its-kind clinical trial. “Holmes and Sanacora will compare the efficacy of ketamine (six infusions administered intravenously over three weeks) to placebo in 50 individuals with Parkinson’s disease and depression. Using cutting-edge brain imaging they will also study the mechanistic effects of ketamine on synaptic connections and functional networks in the brain.” In a similar vein, we recently launched the Psychedelic Palliative Care by Novamind program earlier this fall. It’s a program that supports the mental health of adults coping with serious or chronic physical illness such as cancer, heart disease, Parkinson’s or pain conditions. Learn more here.
